ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 339

More Inflammatory Signs on Ultrasound, Severe Pain and Stiffness Are Associated with Erosive Than Non-Erosive Hand Osteoarthritis

Olga Sleglova1, Olga Ruzickova2, Karel Pavelka1 and Ladislav Senolt2, 1Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: hand disorders and pain, OA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Osteoarthritis - Clinical Aspects Poster I: Treatments and Metabolic Risk Factors

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hand osteoarthritis (HOA) causes considerable pain and disability. Radiographic HOA features show only a modest association with symptoms in HOA. Ultrasound is an easy non-invasive procedure, which is able to visualize synovial inflammation and joint effusion. HOA is a heterogeneous group of disorders with two main subsets including non-erosive disease and erosive, sometimes referred to as inflammatory, HOA. Few studies demonstrated inflammatory ultrasound changes and more severe clinical symptoms in patients with erosive compared with non-erosive disease, however the results are inconclusive.

Methods: The aim of the study was to compare pain, stiffness, physical impairment and ultrasound features between patients with erosive and non-erosive HOA in a cross-sectional study. Consecutive patients with symptomatic HOA fulfilling the American College of Rheumatology (ACR) criteria were included in this study. Joint pain and swelling were assessed. Patients reported joint pain on 100 mm visual analogue scale (VAS). Pain, joint stiffness and disability were assessed by the Australian/Canadian OA hand index (AUSCAN). Radiographs of both hands were examined and erosive disease was defined by at least one erosive interphalangeal joint. Synovial hypertrophy and power Doppler signal (PDS) were scored with ultrasound. Synovitis was graded on a scale of 0–3 and osteophytes were defined as cortical protrusions seen in two planes. 

Results: Altogether, 134 patients (13 male) with symptomatic nodal HOA were included in this study between April 2012 and January 2015. Out of these patients, 72 had erosive disease. Patient’s characteristics are given in table 1. The disease duration (p<0.01), duration of morning stiffness (p<0.01) and number of clinically swollen joints (p<0.05) were significantly higher in patients with erosive compared with non-erosive disease. According to the AUSCAN, patients with erosive compared with non-erosive disease had more pain (p<0.05) and stiffness (p<0.01). US-detected pathologies such as gray-scale synovitis total score (p<0.001), intensity of PDS (p<0.01) and number of osteophytes (p<0.01) were significantly higher in patients with erosive compared with non-erosive disease (table 1). There were no significant differences in consumption of non-steroidal anti-inflammatory drugs (NSAIDs), analgesics and symptomatic slow-acting drugs (SYSADOA) for OA between both groups.

Table 1.

 

All patients

Non-erosive HOA

Erosive HOA

P

Age, years (mean ± SD)

65.98 ± 8.16

64.25 ± 7.61

67.48 ± 8.33

NS

Female, no. (%)

121 (90.29%)

55 (88.70%)

66 (91.66%)

NS

Disease duration (years)

8.54 ± 7.14

7.52 ± 7.02

9.42 ± 7.13

<0.01 *

BMI, kg/m2

27.53 ± 4.33

27.50 ± 4.12

27.55 ± 4.49

NS

AUSCAN, total

21.60 ± 10.44

20.05 ± 9.98

22.93 ± 10.65

<0.05 *

AUSCAN A, pain

8.16 ± 4.26

7.73 ± 4.18

8.53 ± 4.29

<0.05 *

AUSCAN B, function

1.96 ± 0.87

2.02 ± 0.98

1.90 ± 0.77

NS

AUSCAN C, stiffness

11.34 ± 6.27

10.16 ± 5.78

12.36 ± 6.48

<0.01 *

VAS, pain (mm)

43.91 ± 21.42

41.85 ± 21.49

45.69 ± 21.19

NS

Morning stiffness (min)

21.12± 37.84

18.55± 29.06

23.34± 43.89

<0.01 *

Tender joints, no.

7.66 ± 3.34

7.32 ± 3.41

7.96 ± 3.25

NS

Swollen joints, no.

3.69 ± 4.42

3.45 ± 3.86

3.89 ± 4.78

<0.05 *

Ultrasound

 

 

 

 

Synovial hypertrophy

6.72 ± 8.06

4.47 ± 6.09

8.67 ± 8.99

<0.001*

Power Doppler signal

1.99 ± 2.72

1.61 ± 2.07

2.31 ± 3.14

<0.01*

Osteophytes, no.

11.95 ± 5.31

10.6 ± 5.59

13.11 ± 4.76

<0.01*

 * Significantly higher in patients with erosive HOA 

Conclusion: In general, this study shows that patients with erosive HOA have more severe pain and stiffness associated with US-detected synovial hypertrophy, inflammatory signs and osteophyte formation than patients with non-erosive disease.


Disclosure: O. Sleglova, None; O. Ruzickova, None; K. Pavelka, None; L. Senolt, None.

To cite this abstract in AMA style:

Sleglova O, Ruzickova O, Pavelka K, Senolt L. More Inflammatory Signs on Ultrasound, Severe Pain and Stiffness Are Associated with Erosive Than Non-Erosive Hand Osteoarthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/more-inflammatory-signs-on-ultrasound-severe-pain-and-stiffness-are-associated-with-erosive-than-non-erosive-hand-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/more-inflammatory-signs-on-ultrasound-severe-pain-and-stiffness-are-associated-with-erosive-than-non-erosive-hand-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology